Sobuzoxane (MST-16) is an orally active topoisomerase II inhibitor. Sobuzoxane causes irreversible inhibition of cell division. Sobuzoxane can be used in the study of non-Hodgkins lymphoma that is resistant to conventional chemotherapy or has recurred[1].
Molecular Weight:
514.53
Purity:
98.05
CAS Number:
[98631-95-9]
Formula:
C22H34N4O10
Target:
Topoisomerase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted